What is the treatment for breast engorgement?

You may find that your breasts become larger and feel heavy, warmer and uncomfortable when your milk ‘comes in’, usually about 2–6 days after your baby is born. This is normal. It does not affect milk flow or the ability of your baby to attach to your breast.

However, in some cases, a mother’s breasts can become very hard, swollen and tender and her nipples become flattened and taut. This is engorgement and is caused by a build-up of milk, blood and other fluids in the breast tissue. It can be painful for the mother and make it difficult for a baby to attach to the breast.

How can I prevent engorgement?

  • Feed your baby often from birth.
  • Don’t limit baby’s time at the breast.
  • Wake your baby for a feed if your breasts become full and uncomfortable (especially at night time).
  • Ensure your baby is positioned and attached correctly, to maximise the amount of milk she is getting.

How can I relieve engorgement?

  • Take your bra off completely before beginning to breastfeed.
  • Gentle breast massage or use of warmth for up to a few minutes before feeds may help trigger your let-down reflex.
  • If your baby has trouble attaching to your breast, use ‘reverse pressure softening’ (see below) to soften the breast tissue under your areola or express some milk (by hand or with a pump).
  • Feed your baby frequently.
  • Massage the breast gently while you are feeding.
  • If necessary, express for comfort after feeds.
  • Use cold packs or chilled, washed, cabbage leaves after a feed to reduce inflammation.
  • Ask your medical adviser or hospital staff about taking anti-inflammatory medication or pain relief if needed.

‘Reverse pressure softening’: The aim is to push fluid in the tissue under the nipple and areola further back into the breast, to relieve the pressure. To do this, apply pressure with two or three fingers of each hand placed flat at the sides of and close to your nipple, and hold for 1–3 minutes. Or use all fingertips of one hand around the nipple and push in, holding for 1–3 minutes, until the tissue softens. Find more information on reverse pressure softening including diagrams showing how to do it. You can also watch a video on reverse pressure softening here.

For severe engorgement: 

A small percentage of mothers experience severe engorgement around the time their 'milk comes in'. In these situations, it is important to ensure that the baby is attaching well and feeding effectively, and that the length and frequency of feeds are being determined by the baby's needs. In addition, mothers who experience severe engorgement often find it helpful to use a breast pump to completely express out the milk from their breasts.

Engorgement in the armpit

A small percentage of mothers have extra breast tissue in the axilla (armpit). This extra breast tissue is called accessory (or supernumerary) breast tissue and is not connected to the main ductal network of the breast. Accessory breast tissue is different to the breast tissue that normally extends into the armpit (called the Tail of Spence). The Tail of Spence or accessory breast tissue can become engorged just like any other breast tissue can. Management for engorgement, regardless of what breast tissue it occurs in, is the same. 

Further information

Contact the Breastfeeding Helpline or email counselling for further information and support.

The information on this website does not replace the advice of your health care provider.

What is the treatment for breast engorgement?

Breastfeeding: breast and nipple care

Breastfeeding: Breast and Nipple Care tells you what to expect as your breasts change during pregnancy and briefly covers how breastfeeding works.

What is the treatment for breast engorgement?

© Australian Breastfeeding Association December 2019

Breast engorgement is a painful condition affecting large numbers of women in the early postpartum period. It may lead to premature weaning, cracked nipples, mastitis and breast abscess. Various forms of treatment for engorgement have been studied but so far little evidence has been found on an effective intervention.

This is an update of a systematic review first published by Snowden et al. in 2001 and subsequently published in 2010. The objective of this update is to seek new information on the best forms of treatment for breast engorgement in lactating women.

We identified studies for inclusion through the Cochrane Pregnancy and Childbirth Group's Trials Register (30 June 2015) and searched reference lists of retrieved studies.

Randomised and quasi‐randomised controlled trials.

Two review authors independently assessed trials for eligibility, extracted data and conducted 'Risk of bias' assessments. Where insufficient data were presented in trial reports, we attempted to contact study authors and obtain necessary information. We assessed the quality of the evidence using the GRADE approach.

In total, we included 13 studies with 919 women. In 10 studies individual women were the unit of analysis and in three studies, individual breasts were the unit of analysis. Four out of 13 studies were funded by an agency with a commercial interest, two received charitable funding, and two were funded by government agencies.

Trials examined interventions including non‐medical treatments: cabbage leaves (three studies), acupuncture (two studies), ultrasound (one study), acupressure (one study), scraping therapy (Gua Sha) (one study), cold breast‐packs and electromechanical massage (one study), and medical treatments: serrapeptase (one study), protease (one study) and subcutaneous oxytocin (one study). The studies were small and used different comparisons with only single studies contributing data to outcomes of this review. We were unable to pool results in meta‐analysis and only seven studies provided outcome data that could be included in data and analysis.

Non‐medical

No differences were observed in the one study comparing acupuncture with usual care (advice and oxytocin spray) (risk ratio (RR) 0.50, 95% confidence interval (CI) 0.13 to 1.92; one study; 140 women) in terms of cessation of breastfeeding. However, women in the acupuncture group were less likely to develop an abscess (RR 0.20, 95% CI 0.04 to 1.01; one study; 210 women), had less severe symptoms on day five (RR 0.84, 95% CI 0.70 to 0.99), and had a lower rate of pyrexia (RR 0.82, 95% CI 0.72 to 0.94) than women in the usual care group.

In another study with 39 women comparing cabbage leaf extract with placebo, no differences were observed in breast pain (mean difference (MD) 0.40, 95% CI ‐0.67 to 1.47; low‐quality evidence) or breast engorgement (MD 0.20, 95% CI ‐0.18 to 0.58; low‐quality evidence). There was no difference between ultrasound and sham treatment in analgesic requirement (RR 0.98, 95% CI 0.63 to 1.51; one study; 45 women; low‐quality evidence). A study comparing Gua‐Sha therapy with hot packs and massage found a marked difference in breast engorgement (MD ‐2.42, 95% CI ‐2.98 to ‐1.86; one study; 54 women), breast pain (MD ‐2.01, 95% CI ‐2.60 to ‐1.42; one study; 54 women) and breast discomfort (MD ‐2.33, 95% CI ‐2.81 to ‐1.85; one study; 54 women) in favour of Gua‐Sha therapy five minutes post‐intervention, though both interventions significantly decreased breast temperature, engorgement, pain and discomfort at five and 30 minutes post‐treatment.

Results from individual trials that could not be included in data analysis suggested that there were no differences between room temperature and chilled cabbage leaves and between chilled cabbage leaves and gel packs, with all interventions producing some relief. Intermittent hot/cold packs applied for 20 minutes twice a day were found to be more effective than acupressure (P < 0.001). Acupuncture did not improve maternal satisfaction with breastfeeding. In another study, women who received breast‐shaped cold packs were more likely to experience a reduction in pain intensity than women who received usual care; however, the differences between groups at baseline, and the failure to observe randomisation, make this study at high risk of bias. One study found a decrease in breast temperature (P = 0.03) following electromechanical massage and pumping in comparison to manual methods; however, the high level of attrition and alternating method of sequence generation place this study at high risk of bias.

Medical

Women treated with protease complex were less likely to have no improvement in pain (RR 0.17, 95% CI 0.04 to 0.74; one study; 59 women) and swelling (RR 0.34, 95% CI 0.15 to 0.79; one study; 59 women) on the fourth day of treatment and less likely to experience no overall change in their symptoms or worsening of symptoms (RR 0.26, 95% CI 0.12 to 0.56). It should be noted that it is more than 40 years since the study was carried out, and we are not aware that this preparation is used in current practice. Subcutaneous oxytocin provided no relief at all in symptoms at three days (RR 3.13, 95% CI 0.68 to 14.44; one study; 45 women).

Serrapeptase was found to produce some relief in breast pain, induration and swelling, when compared to placebo, with a fewer number of women experiencing slight to no improvement in overall breast engorgement, swelling and breast pain.

Overall, the risk of bias of studies in the review is high. The overall quality as assessed using the GRADE approach was found to be low due to limitations in study design and the small number of women in the included studies, with only single studies providing data for analysis.

Although some interventions such as hot/cold packs, Gua‐Sha (scraping therapy), acupuncture, cabbage leaves and proteolytic enzymes may be promising for the treatment of breast engorgement during lactation, there is insufficient evidence from published trials on any intervention to justify widespread implementation. More robust research is urgently needed on the treatment of breast engorgement.


Page 2

Cabbage cream for breast engorgement during lactation

Cabbage cream for breast engorgement during lactation
Patient or population: women with breast engorgement during lactation
Settings: Royal Darwin and Darwin Private Hospital, Australia
Intervention: cabbage cream
Comparison: placebo
OutcomesIllustrative comparative risks* (95% CI)Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed riskCorresponding risk
Control Cabbage cream
Breast pain
Bourbonaise pain scale
 The mean breast pain in the intervention groups was
0.4 higher
(0.67 lower to 1.47 higher)
 39
(1 study)
⊕⊕⊝⊝
low1,2
Higher score indicates more pain ‐ Bourbonaise pain scale ranks pain on a scale from 0 to 10, with 0 representing no pain and 10 representing excruciating pain.
Breast induration/hardness     This outcome was not reported in the trial.
Breast swelling     This outcome was not reported in the trial.
Breast engorgement Hill and Humenich Breast engorgement scale

Follow‐up: mean 4 days

 The mean engorgement in the intervention groups was
0.2 higher
(0.18 lower to 0.58 higher)
 39
(1 study)
⊕⊕⊝⊝
low1,2
Higher score indicates more engorgement ‐ Hill and Humenich Breast engorgement scale ranks engorgement on a scale from 0 to 6, with 0 representing soft, no change in breasts and 6 representing very firm, very tender.
Analgesic requirement     This outcome was not reported in the trial.
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.